Citadel Advisors’s Intercure INCR Stock Holding History

Citadel Advisors’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-180	Closed	-$1.26K	–	13730
2025 Q1	$1.26K	Buy	180 +80	+80%	+$646	﹤0.01%	14152
2024 Q4	$800	Buy	100 +80	+400%	+$629	﹤0.01%	14267
2024 Q3	$201	Sell	20 -20	-50%	-$210	﹤0.01%	14077
2024 Q2	$402	Sell	40 -20	-33%	-$272	﹤0.01%	14003
2024 Q1	$813	Sell	60 -40	-40%	-$340	﹤0.01%	14242
2023 Q4	$640	Sell	100 -320	-76%	-$1.95K	﹤0.01%	13978
2023 Q3	$3.32K	Sell	420 -360	-46%	-$2.87K	﹤0.01%	13601
2023 Q2	$6.63K	Buy	780 +180	+30%	+$1.97K	﹤0.01%	13414
2023 Q1	$6.12K	Buy	+600	New	+$9.02K	﹤0.01%	13828

Other funds holding INCR

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Quent Capital New York $1.63B AUM 27.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's INCR Position: Q2 2026 in Review

Citadel Advisors reduced its Intercure (INCR) stake by 19% in Q2 2026, selling an estimated $23.1K and leaving 21,583 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #12547.

Citadel Advisors first reported a position in INCR in Q3 2021 and has held it in 20 quarters since. The position peaked at $206K in Q4 2021. 16 funds tracked by Wall St. Rank hold INCR as of Q2 2026.

Citadel Advisors held 21,583 shares of Intercure worth $119K as of Q2 2026.
Citadel Advisors sold 5,201 Intercure shares in Q2 2026, an estimated $23.1K.
Intercure made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12547 holding.
Citadel Advisors first reported a position in Intercure in Q3 2021 and has held it in 20 quarters since.
Citadel Advisors's Intercure position peaked at $206K in Q4 2021.
16 funds tracked by Wall St. Rank held Intercure as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.